Human Innate Immune Variation
人类先天免疫变异
基本信息
- 批准号:8236986
- 负责人:
- 金额:$ 46.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAffectAgonistAllelesAlveolar MacrophagesCell DeathCenters of Research ExcellenceCessation of lifeDNADataEmerging Communicable DiseasesEnrollmentFrancisella tularensisFrequenciesFunctional disorderFundingGene ExpressionGenesGeneticGenetic PolymorphismGenetic VariationGenomicsGenotypeGoalsHeritabilityHumanImmuneImmune responseIn VitroIndividualIndividual DifferencesInfectionIntegration Host FactorsKnock-in MouseLifeLipopolysaccharidesMeasuresMediatingModelingMusOrganPathway interactionsPatientsPhenotypePopulationPredispositionPreventiveResourcesRoleSamplingSepsisSeptic ShockStructureTLR1 geneTLR2 geneTLR4 geneTLR7 geneToll-like receptorsVariantWhole BloodWorkYersiniaYersinia pestisantimicrobialbiodefensecytokinegenetic variantgenome wide association studyhealthy volunteerhigh riskin vivoinsightmonocytenovelpathogenprotein expressionprotein functionreceptorresponse
项目摘要
This project is focused on the identification of factors that could alter human susceptibility to bioweapons
agents. This is an important goal, as we need to be able to identify high-risk groups in order to target
effective preventive measures. Our work to date has resulted in several important findings: 1) the
existence of a high degree of inter-individual variation in human innate immune responses to a diverse
range of innate immune agonists, 2) determined that a large proportion of this inter-individual variation is
due to heritable factors, 3) the identification of numerous common genetic variants within genes of the tolllike
receptor (TLR) response pathway that are highly associated with innate immune responses measured
in vitro, 4) the identification of a highly functional genetic variant in the gene for TLR1 that dramatically
alters TLR1-mediated responses and predicts organ dysfunction and death in patients with sepsis and
septic shock. The studies proposed in this renewal will continue to address the Primary Hypothesis:
Inter-individual variability in innate immune responses to potential bioweapons agents such as Y.
pestis is modified by specific genetic variants, which influence host susceptibility to infection.
Over the course of the prior funding period we have enrolled and characterized innate immune responses
to a large panel of agonists in over 800 healthy volunteers for whom we have also collected genomic DNA
samples. We will employ this unique resource in addition to proposed core resources as part of this RCEB
application to further our understanding of how genetic factors modify human host susceptibility to
infection. In Aim 1 we will perform a genome-wide association study to identify novel genetic factors
predicting very high or very low whole blood cytokine responses to TLR4, TLR7/8, and NOD2 agonists ex
vivo. In Aim 2 we will determine the effect of genetic polymorphisms in TLR pathway-related genes on the
response of monocytes and alveolar macrophages to infection with select agents in vitro. Finally, in Aim 3
we will determine the role of human TLR1 polymorphisms on infection with Y.pestis and F.tularensis in vivo
in mice. Through these proposed studies will gain important new insights into the genetic control of innate
immune responses to bacterial products from important select agents and how these genetically controlled
responses affect host responses to live pathogens in vitro and in vivo.
该项目的重点是确定可能改变人类对生化武器易感性的因素。
探员们。这是一个重要的目标,因为我们需要能够识别高危群体,以便针对
有效的预防措施。到目前为止,我们的工作已经产生了几个重要的发现:1)
存在高度个体间差异的人类先天免疫反应的多样性
先天免疫激动剂的范围,2)决定了这种个体间变异的很大比例是
由于遗传因素,3)确定了许多常见的遗传变异的基因内的托尔样
受体(TLR)反应途径与测量的先天免疫反应高度相关
在体外,4)在TLR1基因中鉴定出一个高功能的遗传变异,该变异显著地
脓毒症患者TLR1介导的反应改变并预测器官功能障碍和死亡
感染性休克。本次更新中提出的研究将继续解决基本假设:
对潜在生物武器制剂的先天免疫反应的个体间差异。
鼠疫病毒被特定的遗传变异所修饰,这些变异影响宿主对感染的易感性。
在之前的资助期中,我们已经登记并表征了先天免疫反应。
给800多名健康志愿者的一大批激动剂,我们也为他们收集了基因组DNA
样本。除了建议的核心资源外,我们还将利用这一独特的资源作为RCEB的一部分
应用来加深我们对遗传因素如何改变人类宿主对
感染。在目标1中,我们将进行全基因组关联研究,以确定新的遗传因素。
预测对TLR4、TLR7/8和NOD2激动剂EX的全血细胞因子应答很高或很低
活着。在目标2中,我们将确定TLR途径相关基因的遗传多态对TLR信号转导的影响。
体外单核细胞和肺泡巨噬细胞对选择性药物感染的反应。最后,在目标3中
我们将在活体内确定人类TLR1基因多态性在鼠疫杆菌和图拉氏杆菌感染中的作用
在老鼠身上。通过这些拟议的研究,将获得对先天遗传控制的重要新见解
对来自重要选择制剂的细菌产品的免疫反应以及这些免疫反应是如何由基因控制的
在体外和体内,反应影响宿主对活体病原体的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas R Martin其他文献
THE ROLES OF ALLOREACTIVITY AND ENDOTOXIN IN AN EXPERIMENTAL MODEL OF IDIOPATHIC PNEUMONIA SYNDROME AFTER BONE MARROW TRANSPLANTATION. • 909
- DOI:
10.1203/00006450-199604001-00931 - 发表时间:
1996-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Kenneth R Cooke;Thomas R Martin;Lester Kobzik;Joanne Brewer;John Delmonte;James L.M Ferrara - 通讯作者:
James L.M Ferrara
Thomas R Martin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas R Martin', 18)}}的其他基金
Acute Lung Injury: Link Between Apoptosis and Fibrosis
急性肺损伤:细胞凋亡与纤维化之间的联系
- 批准号:
7637452 - 财政年份:2007
- 资助金额:
$ 46.78万 - 项目类别:
Acute Lung Injury: Link Between Apoptosis and Fibrosis
急性肺损伤:细胞凋亡与纤维化之间的联系
- 批准号:
7496108 - 财政年份:2007
- 资助金额:
$ 46.78万 - 项目类别:
"Acute lung injury: link between apoptosis and fibrosis"
“急性肺损伤:细胞凋亡和纤维化之间的联系”
- 批准号:
7198426 - 财政年份:2007
- 资助金额:
$ 46.78万 - 项目类别:
SCCOR in Translational Research in Acute Lung Injury
SCCOR 在急性肺损伤转化研究中的应用
- 批准号:
6851348 - 财政年份:2003
- 资助金额:
$ 46.78万 - 项目类别:
SCCOR in Translational Research in Acute Lung Injury
SCCOR 在急性肺损伤转化研究中的应用
- 批准号:
6673301 - 财政年份:2003
- 资助金额:
$ 46.78万 - 项目类别:
SCCOR in Translational Research in Acute Lung Injury
SCCOR 在急性肺损伤转化研究中的应用
- 批准号:
6936545 - 财政年份:2003
- 资助金额:
$ 46.78万 - 项目类别:
SCCOR in Translational Research in Acute Lung Injury
SCCOR 在急性肺损伤转化研究中的应用
- 批准号:
7281176 - 财政年份:2003
- 资助金额:
$ 46.78万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant